A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Completed · Phase 4

Conditions studied: Dry Eye

In brief

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

Key facts

Study ID

NCT00399230

Run by

Innovative Medical

Last updated by the study team

2007-08-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• · Dry eye disease diagnosis
• Patients must currently be using Systane tears at least once a day and for at least 1 month.
• Normal lid position and closure
• Male or female of legal age of consent
• Informed consent has been obtained
• Likely to complete all required follow-up visits

You may not qualify if…

• · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.
• Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.

Where it is running

• Dr. Rajpal — McLean, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.